F. Ikeda

发表

Involvement of platelets in extrahepatic metastasis of hepatocellular carcinoma

H. Shiraha, K. Kuwaki, A. Takaki, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

The involvement of platelets in extra-hepatic metastasis of hepatocellular carcinoma

H. Shiraha, K. Kuwaki, A. Takaki, 2014 .

A subclinical high tricuspid regurgitation pressure gradient independent of the mean pulmonary artery pressure is a risk factor for the survival after living donor liver transplantation

T. Fujiwara, H. Shiraha, A. Takaki, 2018, BMC Gastroenterology.

Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.

K. Reddy, J. McKeating, K. Sugimoto, 2007, Gastroenterology.

BASIC-LIVER, PANCREAS, AND BILIARY TRACT Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C

K. Reddy, J. McKeating, K. Sugimoto, 2007 .

Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection

K. Sugimoto, Kyong‐Mi Chang, F. Nunes, 2005, Journal of Virology.

Assessment of health‐related quality of life and how it predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C

A. Takaki, K. Nouso, Kazuhide Yamamoto, 2014, Journal of gastroenterology and hepatology.

Assessment of health-related quality of life predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C 1

A. Takaki, K. Nouso, Kazuhide Yamamoto, 2013 .

Serum oxidative–anti‐oxidative stress balance is dysregulated in patients with hepatitis C virus‐related hepatocellular carcinoma

K. Kuwaki, H. Hagihara, A. Takaki, 2013, Hepatology research : the official journal of the Japan Society of Hepatology.

Prognostic importance of fucosylated alpha‐fetoprotein in hepatocellular carcinoma patients with low alpha‐fetoprotein

H. Shiraha, K. Kuwaki, H. Hagihara, 2011, Journal of gastroenterology and hepatology.

Oxidative stress balance is dysregulated and represents an additional target for treating cholangiocarcinoma

T. Fujiwara, H. Shiraha, A. Takaki, 2016, Free radical research.

Prognotic impact of serum follistatin in patients with hepatocellular carcinoma

H. Shiraha, K. Kuwaki, H. Hagihara, 2013, Journal of gastroenterology and hepatology.

Roles of alcohol drinking pattern in fatty liver in Japanese women

Kazuhide Yamamoto, F. Ikeda, Y. Iwasaki, 2013, Hepatology International.

Alcohol consumption appears to protect against non‐alcoholic fatty liver disease

F. Ikeda, H. Taniguchi, Akio Moriya, 2011, Alimentary pharmacology & therapeutics.

Alcohol for patients with non-alcoholic fatty liver disease: Friend or foe?

F. Ikeda, Y. Iwasaki, Akio Moriya, 2011 .

+49A/G polymorphism of cytotoxic T‐lymphocyte antigen 4 gene in type 1 autoimmune hepatitis and primary biliary cirrhosis: A meta‐analysis

A. Takaki, K. Nouso, Kazuhide Yamamoto, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

Anti-viral actions and viral dynamics in the early phase of three different regimens of interferon treatment for chronic hepatitis C: differences between the twice-daily administration of interferon-beta treatment and the combination therapy with interferon-alpha plus ribavirin.

Y. Shiratori, F. Ikeda, H. Nakajima, 2003, Acta medica Okayama.

Treatment of over 20 mm gastric cancer by endoscopic submucosal dissection using an insulation-tipped diathermic knife.

M. Matsubara, S. Hirasaki, Seiyuu Suzuki, 2007, World journal of gastroenterology.

Clinical features of type 1 autoimmune hepatitis in adolescence and early adulthood

A. Takaki, Kazuhide Yamamoto, T. Yasunaka, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma

H. Shiraha, K. Kuwaki, H. Hagihara, 2011, Journal of gastroenterology and hepatology.

Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma

H. Shiraha, K. Kuwaki, H. Hagihara, 2012, Journal of Gastroenterology.

Serum levels of platelet‐derived growth factor‐BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure

H. Shiraha, A. Takaki, K. Nouso, 2011, Journal of gastroenterology and hepatology.

Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C

Hideki Ohnishi, A. Takaki, K. Nouso, 2015, Journal of Clinical Pathology.

Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?

T. Fujiwara, H. Shiraha, A. Takaki, 2013, Journal of Gastroenterology.

Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib

H. Shiraha, H. Hagihara, A. Takaki, 2018, Journal of gastroenterology and hepatology.

Evaluation of the effect of sorafenib using serum NX‐des‐γ‐carboxyprothrombin in patients with hepatocellular carcinoma

H. Shiraha, K. Kuwaki, H. Hagihara, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Title: Potential of alpha-fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma

H. Shiraha, K. Kuwaki, A. Takaki, 2017 .

Potential of alpha‐fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma

H. Shiraha, K. Kuwaki, A. Takaki, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Long‐term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine

A. Takaki, Shinichiro Nakamura, K. Nouso, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

Anti‐programmed cell death‐1 antibody as a new serological marker for type 1 autoimmune hepatitis

H. Shiraha, A. Takaki, K. Nouso, 2014, Journal of gastroenterology and hepatology.

Necessity for Reassessment of Patients with Serogroup 2 Hepatitis C Virus (HCV) and Undetectable Serum HCV RNA

Kazuhide Yamamoto, Y. Takeuchi, F. Ikeda, 2013, Journal of Clinical Microbiology.

Ledipasvir‐sofosbuvir for treating Japanese patients with chronic hepatitis C virus genotype 2 infection

N. Enomoto, Y. Takikawa, Y. Asahina, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial.

T. Ide, N. Izumi, H. Mo, 2015, The Lancet. Infectious diseases.

Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals

K. Chayama, T. Ide, M. Kurosaki, 2018, Hepatology International.

Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open‐label, phase 3 trial

T. Ide, N. Izumi, O. Yokosuka, 2014, Journal of viral hepatitis.

Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative Colitis

H. Shiraha, A. Takaki, K. Nouso, 2013, PloS one.

TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: Relationship with clinical characteristics

H. Shiraha, A. Takaki, K. Nouso, 2015, Journal of gastroenterology and hepatology.

Obstructions of portal veins and tumor numbers are associated with humped hepatocellular carcinoma.

Y. Nishiyama, Seiyuu Suzuki, F. Ikeda, 2010, Acta medica Okayama.

Plasma Arginase-1 Level Is Associated with the Mental Status of Outpatients with Chronic Liver Disease

N. Suganuma, K. Ogino, H. Okada, 2021, Diagnostics.

Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B

K. Chayama, N. Hiramatsu, Y. Kondo, 2020, Journal of Gastroenterology.

Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy

K. Chayama, M. Kurosaki, N. Hiramatsu, 2018, Journal of Gastroenterology.

Fucosylated-hemopexin and HCC 1 1 Clinical utility of serum Fucosylated-hemopexin in Japanese patients with Hepatocellular Carcinoma

H. Shiraha, K. Kuwaki, H. Hagihara, 2013 .

Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease

H. Shiraha, A. Takaki, K. Nouso, 2010, Journal of Gastroenterology.

Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C

Hideki Ohnishi, A. Takaki, K. Nouso, 2013, SpringerPlus.

Alpha-fetoprotein before and after pegylated interferon therapy for predicting hepatocellular carcinoma development.

Hideki Ohnishi, A. Takaki, K. Nouso, 2015, World journal of hepatology.

Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis

H. Kiyonari, A. Takaki, Kazuhide Yamamoto, 2015, Scientific Reports.

L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway

H. Shiraha, A. Takaki, K. Nouso, 2014, PloS one.

High Prevalence of TT Virus in Human Bile Juice Samples

T. Tsuji, F. Ikeda, H. Tsuji, 2001, Digestive Diseases and Sciences.

The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma

K. Kuwaki, A. Takaki, Shinichiro Nakamura, 2017, Internal medicine.

Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis.

Kyong‐Mi Chang, F. Nunes, F. Ikeda, 2008, Journal of hepatology.

Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma

H. Shiraha, K. Kuwaki, H. Hagihara, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Strain-Speciﬁc T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection

K. Sugimoto, F. Nunes, H. Alter, 2005 .

Amino acid substitutions of hepatitis C virus core protein are not associated with intracellular antiviral response to interferon‐α in vitro

N. Kato, M. Ikeda, A. Takaki, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease

H. Shiraha, A. Takaki, K. Nouso, 2016, Hepatology International.

A case of Wilson’s disease with characteristic laparoscopic findings

H. Shiraha, A. Takaki, Kazuhide Yamamoto, 2014, Clinical Journal of Gastroenterology.

Evolution of prognostic factors in hepatocellular carcinoma in Japan

H. Shiraha, K. Kuwaki, H. Hagihara, 2010, Alimentary pharmacology & therapeutics.

Hepatopulmonary syndrome in Japanese liver cirrhosis patients

T. Fujiwara, A. Takaki, T. Yagi, 2014 .

Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors

T. Fujiwara, H. Shiraha, A. Takaki, 2015, Transplantation.

Title: Serum levels of soluble adhesion molecules as prognostic factors for acute liver failure. Running title: Serum sPECAM-1 and sICAM-1 level in ALF

H. Shiraha, A. Takaki, K. Nouso, 2013 .

Serum Levels of Soluble Adhesion Molecules as Prognostic Factors for Acute Liver Failure

H. Shiraha, A. Takaki, K. Nouso, 2012, Digestion.

Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection.

John F. Flaherty, W. Seto, Y. Asahina, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Hepatitis C virus-specific T-cell response correlates with hepatitis activity and donor IL28B genotype early after liver transplantation.

T. Fujiwara, H. Shiraha, A. Takaki, 2014, Acta medica Okayama.

Autoimmune hepatitis with acute presentation in Japan.

A. Takaki, T. Yasunaka, F. Ikeda, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid

A. Takaki, Kazuhide Yamamoto, Y. Takeuchi, 2011, Journal of gastroenterology and hepatology.

Mortality rate of patients with asymptomatic primary biliary cirrhosis diagnosed at age 55 years or older is similar to that of the general population

Kazuhide Yamamoto, T. Yasunaka, F. Ikeda, 2009, Journal of Gastroenterology.

Risk of secondary osteoporosis due to lobular cholestasis in non‐cirrhotic primary biliary cholangitis

Kazuhide Yamamoto, H. Okada, F. Ikeda, 2017, Journal of gastroenterology and hepatology.

Daclatasvir/asunaprevir/beclabuvir fixed-dose combination in Japanese patients with HCV genotype 1 infection

H. Yoshiji, K. Chayama, Y. Karino, 2017, Journal of Gastroenterology.

Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: A 5‐year study of patients with hepatitis B with lamivudine resistance

A. Takaki, Kazuhide Yamamoto, Y. Takeuchi, 2012, Journal of medical virology.

Human Telomerase Reverse Transcriptase Gene Promoter Mutation in Serum of Patients with Hepatocellular Carcinoma

H. Shiraha, A. Takaki, K. Nouso, 2020, Oncology.

Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients.

J. Toshimori, A. Takaki, Kazuhide Yamamoto, 2016, Acta Medica Okayama.

Randomized trial of peginterferon alpha‐2b plus low and escalating dose of ribavirin in patients with chronic hepatitis C with high viral load genotype 1

A. Takaki, Kazuhide Yamamoto, F. Ikeda, 2015, Journal of medical virology.

Reactivation of hepatitis B virus during interferon‐free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus/hepatitis C virus co‐infection

F. Ikeda, S. Fujiki, Hiroki Takayama, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Alteration of N‐glycan profiles in patients with chronic hepatitis and hepatocellular carcinoma

H. Shiraha, K. Kuwaki, A. Takaki, 2015, Hepatology Research.

Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer

H. Shiraha, K. Kuwaki, H. Hagihara, 2013, Journal of Gastroenterology.

Prevalence and outcomes of acute hepatitis B in Okayama, Japan, 2006-2010.

J. Toshimori, A. Takaki, Kazuhide Yamamoto, 2014, Acta medica Okayama.

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis

H. Shiraha, A. Takaki, T. Yagi, 2011, Hepatology international.

Predictive Factors for Successful Vaccination Against Hepatitis B Surface Antigen in Patients Who Have Undergone Orthotopic Liver Transplantation.

Kazuhiro Yoshida, T. Fujiwara, H. Shiraha, 2019, Acta medica Okayama.

Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response

E. Furth, C. Brensinger, K. Sugimoto, 2003, Hepatology.

Fulminant hepatitis: Who survives without liver transplantation?

A. Takaki, K. Nouso, Kazuhide Yamamoto, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

SIRS score reflects clinical features of non-acetaminophen-related acute liver failure with hepatic coma.

A. Takaki, K. Nouso, Kazuhide Yamamoto, 2012, Internal medicine.

Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans

K. Sugimoto, Kyong‐Mi Chang, M. Kamoun, 2008, Hepatology.

A sofosbuvir-based direct-acting antiviral treatment regimen exhibits a strong protective effect against post-liver transplantation chronic hepatitis C recurrence

H. Shiraha, Hideki Ohnishi, A. Takaki, 2017 .

A case of fulminant liver failure associated with hepatitis C virus

T. Fujiwara, A. Takaki, K. Nouso, 2014, Clinical Journal of Gastroenterology.

Acute hepatitis due to hepatitis E virus genotype 1 as an imported infectious disease in Japan.

A. Takaki, Kazuhide Yamamoto, T. Yasunaka, 2010, Internal medicine.

Suppression of HCV‐specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection

K. Sugimoto, Kyong‐Mi Chang, F. Nunes, 2003, Hepatology.

Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis

Eijiro Watanabe, A. Takaki, D. Ogawa, 2016, Scientific Reports.

Reassessment necessity of patients with serogroup 2 of hepatitis C virus and undetectable serum HCV RNA

Kazuhide Yamamoto, Y. Takeuchi, F. Ikeda, 2014 .

Prognostic Value of Altered N-Glycosylation of Circulating Glycoproteins in Patients With Unresectable Pancreatic Cancer Treated With Gemcitabine

H. Shiraha, K. Kuwaki, A. Takaki, 2015, Pancreas.

Intravenous Vitamin C as Ancillary Treatment for Cranial Polyneuritis and Meningitis due to Varicella Zoster Virus Reactivation.

Kazuhide Yamamoto, F. Ikeda, T. Hongo, 2020, Acta medica Okayama.

Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element.

N. Kato, F. Ikeda, A. Nozaki, 2003, Virus research.

Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection

H. Yoshiji, K. Chayama, Y. Karino, 2018, Journal of Gastroenterology.

The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis

H. Shiraha, K. Kuwaki, H. Hagihara, 2013, Journal of Gastroenterology.

Low Frequency of Drug-Resistant virus did not Affect the Therapeutic Efficacy in Daclatasvir plus Asunaprevir Therapy in Patients with Chronic HCV Genotype-1 Infection

S. Toyooka, H. Shiraha, A. Takaki, 2016, Antiviral therapy.

Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

K. Chayama, M. Kurosaki, M. Sakamoto, 2018, Journal of Gastroenterology.

Mixed HCV Infection of Genotype 1B and Other Genotypes Influences Non-response during Daclatasvir + Asunaprevir Combination Therapy.

H. Hagihara, A. Takaki, Y. Takeuchi, 2018, Acta medica Okayama.

Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas.

H. Shiraha, K. Kuwaki, A. Takaki, 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis

Kazuhide Yamamoto, T. Yasunaka, H. Okada, 2012, Journal of gastroenterology and hepatology.

Pachydermoperiostosis associated with juvenile polyps of the stomach and gastric adenocarcinoma

Y. Shiratori, H. Okada, M. Mizuno, 2004, Journal of Gastroenterology.

Peritoneovenous shunting for refractory ascites results in worsening of nephrotic syndrome

A. Takaki, T. Yagi, Kazuhide Yamamoto, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

HEPATIC ANGIOSARCOMA WITH CHARACTERISTIC LAPAROSCOPIC FINDINGS

A. Takaki, Kazuhide Yamamoto, T. Yasunaka, 2012, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

Introduction of management system of positive test results for HBV and HCV infection in electronic medical chart

A. Takaki, K. Nouso, Kazuhide Yamamoto, 2015 .

Sufficient management of alert system of positive test results for HBV and HCV infection in electronic medical chart for facilitating hepatological consultation

H. Shiraha, Hideki Ohnishi, A. Takaki, 2017 .

Clinical features of autoimmune hepatitis diagnosed based on simplified criteria of the International Autoimmune Hepatitis Group.

A. Takaki, Kazuhide Yamamoto, T. Yasunaka, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Clinical features of antinuclear antibodies‐negative type 1 autoimmune hepatitis

A. Takaki, Kazuhide Yamamoto, T. Yasunaka, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

A Phase I/Ib trial of Ad-REIC in liver cancer: study protocol.

H. Shiraha, M. Iwamuro, A. Takaki, 2019, Future oncology.

Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary Cirrhosis.

A. Takaki, K. Nouso, Kazuhide Yamamoto, 2015, Acta medica Okayama.

Hepatocellular carcinoma occurring in hepatobiliary fibropolycystic disease

H. Shiraha, K. Kuwaki, H. Hagihara, 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

Serum Oxidative/anti-oxidative Stress Balance Is Dysregulated in Potentially Pulmonary Hypertensive Patients with Liver Cirrhosis: A Case Control Study.

T. Fujiwara, H. Shiraha, A. Takaki, 2015, Internal medicine.

Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma

M. Honda, H. Shiraha, K. Kuwaki, 2013, British Journal of Cancer.

Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma

H. Shiraha, K. Kuwaki, H. Hagihara, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Use of non‐invasive serum glycan markers to distinguish non‐alcoholic steatohepatitis from simple steatosis

H. Shiraha, K. Kuwaki, A. Takaki, 2015, Journal of gastroenterology and hepatology.

Efficacy of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis

A. Takaki, Kazuhide Yamamoto, T. Yasunaka, 2009, Hepatology international.

T‐cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C

K. Reddy, K. Sugimoto, K. Shetty, 2005, Hepatology.

Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C

H. Nomura, H. Yoshiji, K. Ikeo, 2016, PloS one.

Nursing support increases the efficacy of interferon therapy in patients with chronic hepatitis C.

H. Shiraha, A. Takaki, K. Nouso, 2014, Acta medica Okayama.

DIAGNOSTIC USEFULNESS OF LAPAROSCOPY IN A CASE OF HBV CARRIER WITH AUTOIMMUNE HEPATITIS

Kazuhide Yamamoto, T. Tsuji, F. Ikeda, 1999 .

The Efficacy and Safety of Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.

H. Shiraha, K. Kuwaki, H. Hagihara, 2019, Acta medica Okayama.

Gastric inflammatory fibroid polyp treated with Helicobacter pylori eradication therapy.

M. Matsubara, S. Hirasaki, Seiyuu Suzuki, 2007, Internal medicine.

Three cases of Solitary Peutz-Jeghers-type hamartomatous polyp in the duodenum.

M. Matsubara, S. Hirasaki, Seiyuu Suzuki, 2008, World journal of gastroenterology.

A case of childhood autoimmune hepatitis of cirrhotic stage manifested by anemia

H. Shiraha, A. Takaki, K. Nouso, 2013 .

Application of radiofrequency ablation for the treatment of intermediate‐stage hepatocellular carcinoma

H. Shiraha, K. Kuwaki, A. Takaki, 2017, Journal of gastroenterology and hepatology.

Impact of comorbid hepatic steatosis on treatment of chronic hepatitis C in Japanese patients and the relationship with genetic polymorphism of IL28B, PNPLA3 and LDL receptor.

Hideki Ohnishi, A. Takaki, K. Nouso, 2014, Acta medica Okayama.

Effectiveness of extending treatment duration in therapy with pegylated interferon and ribavirin for genotype 2 hepatitis C virus infection.

A. Takaki, Kazuhide Yamamoto, F. Ikeda, 2015, Acta medica Okayama.

Serum oxidative-anti-oxidative stress balance is dysregulated in pulmonary hypertensive patients with liver cirrhosis : a case control study

T. Fujiwara, H. Shiraha, A. Takaki, 2015 .

A Patient with Type 3 Autoimmune Polyglandular Syndrome who Developed Systemic Lupus Erythematosus 8 years after the Diagnosis of Autoimmune Hepatitis.

H. Sugiyama, J. Wada, J. Eguchi, 2019, Acta medica Okayama.

A Case of Human Granulocytic Anaplasmosis Suspected to be Complicated by Cholangitis

N. Ohashi, Manri Kawakami, F. Ikeda, 2022, Kansenshogaku Zasshi.

Successful Recovery from Severe Fever with Thrombocytopenia Syndrome and Hemophagocytic Lymphohistiocytosis with Standard Treatment and a Calcium Channel Blocker of Nicardipine Hydrochloride

Kazuhide Yamamoto, Manri Kawakami, F. Ikeda, 2022, Internal medicine.

Simple screening method for the diagnosis of nonB-nonC hepatocellular carcinoma

H. Shiraha, A. Takaki, K. Nouso, 2018, Hepatoma Research.

Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer

M. Tsujie, Michiya Kobayashi, F. Ikeda, 2016, OncoTargets and therapy.